Naloxone administration to patients with acute stroke.
- 1 January 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 15 (1) , 36-39
- https://doi.org/10.1161/01.str.15.1.36
Abstract
Naloxone, an opiate antagonist, has recently been reported to temporarily reverse neurologic deficits associated with subarachnoid hemorrhage. To determine if this unexpected effect of naloxone might also occur in other forms of cerebrovascular diseases, 13 patients who presented with acute neurologic deficits were administered intravenous naloxone. In 3 of these patients, coincidental improvement in neurologic status was seen. In one patient the improvement was permanent. Ten of the 11 patients with non fatal neurologic damage improved later in their hospital course--7 of them to their pre-admission state. The only side effect noted was the temporally related onset of a single focal seizure in an ethanol intoxicated patient with an intracerebral hemorrhage.This publication has 7 references indexed in Scilit:
- Reversal of Induced Ischemic Neurologic Deficit in Gerbils by the Opiate Antagonist NaloxoneScience, 1981
- Effect of naloxone on posttraumatic ischemia in experimental spinal contusionJournal of Neurosurgery, 1981
- NALOXONE REVERSAL OF ISCHAEMIC NEUROLOGICAL DEFICITS IN MANThe Lancet, 1981
- PRESSOR EFFECT OF NALOXONE IN SEPTIC SHOCKThe Lancet, 1981
- Opiate Antagonists: A Role in the Treatment of Hypovolemic ShockScience, 1979
- Naloxone reversal of endotoxin hypotension suggests role of endorphins in shockNature, 1978
- EFFECTS OF MORPHINE-LIKE AND NALORPHINE-LIKE DRUGS IN NONDEPENDENT AND MORPHINE-DEPENDENT CHRONIC SPINAL DOG1976